Lilly seals up to $7.8 billion deal for Centessa in sleep disorder bet - reuters.com

Lilly seals up to $7.8 billion deal for Centessa in sleep disorder bet  reuters.comEli Lilly to Buy Centessa Pharmaceuticals for Initial $6.3 Billion  WSJEli Lilly Will Buy a Narcolepsy Drug Developer for $6.3 Billion  nytimes.comWith Zepbound approved for sleep apnea, Lilly spends up to $7.8 billion for a company with a narcolepsy drug  MarketWatchLilly pays $6.3B upfront for sleep disorder-focused Centessa in latest neuroscience play  fiercebiotech.com